A study on the effects of application of compounded stenone cream (fermented product enriched with plant stenones) on subcutaneous fat and visceral fat.

A study on the effects of application of compounded stenone cream (fermented product enriched with plant stenones) on subcutaneous fat and visceral fat. - A study on the effects of application of compounded stenone cream (fermented product enriched with plant stenones) on subcutaneous fat and visceral fat.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039249

Enrollment

Registered

2020-01-24

Start date

2020-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Apply 5g of compounded stenone cream (test product) at a time once daily after leaving the bath. Continue it for 8 weeks. Apply 5g of placebo at a time once daily after leaving the bath. Continue it

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. 35 to 64 years old. 2. Women. 3. BMI 25.0 kg/m2 or greater.

Exclusion criteria

Exclusion criteria: 1. Those are currently receiving some types of drug treatment (e.g. treatment affecting obesity, hyperlipidemia, and lipid metabolism). 2. Those who are receiving nutrition therapy or physical therapy under a doctor's supervision. 3. Those who cannot stop taking health foods or supplements (those which may affect obesity, hyperlipidemia, and lipid metabolism) during the study period. 4. Those who cannot stop drinking alcohol the day before a test. 5. Those who have a current or a past medical history of severe diseases. 6. Those who have skin diseases (e.g. atopic dermatitis) or a hypersensitivity. 7. Those who have a current or a past medical history of drug or food allergy. 8. Those who have a current or a past medical history of drug or alcohol dependence. 9. Those who have metals implanted in the body due to surgery etc. 10. Those who have a cardiac pacemaker or an implantable medical device placed in the body. 11. Those who have claustrophobia. 12. Those who work night shifts. 13. Smokers. 14. Those who are currently pregnant or breastfeeding or those who want to become pregnant during the study period. 15. Those who are currently participating in another clinical trial or those who took a test product and completed another clinical trial in a month. 16. Those who were determined by the principal investigator or a sub-investigator to be an unsuitable subject for this study.

Design outcomes

Primary

Measure	Time frame
Subcutaneous fat area	—

Secondary

Measure	Time frame
Visceral fat area, Total fat area, Weight, Body fat percentage, Adiponectin, and Leptin	—

Countries

Japan

Contacts

Public ContactYoshitada Hira

IMEQRD Co., Ltd. Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026